ProPhase Labs (PRPH) Misses Q3 EPS by 33c; Reports Cash and Cash Equivalents of $22.9M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2021
November 12, 2021 8:30 AM ESTCompany to hold a conference call November 12, 2021 at 11:00AM ET
Garden City, NY, Nov. 12, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, today reported its financial and operational results for the three months ended September 30, 2021.
Financial highlights for the quarter ended September 30, 2021 include the following:
Total revenue of $9.5... More